1.Classic Juvenile Pityriasis Rubra Pilaris Treated with Oral Alitretinoin.
Annals of Dermatology 2016;28(3):388-390
No abstract available.
Pityriasis Rubra Pilaris*
;
Pityriasis*
2.A Case of Juvenile Pityriasis Rubra Pilaris Clinically Improved with Cyclosporine.
Hyunseok CHOI ; Sung Soo HAN ; Hyung Kwon PARK ; Jung Woo LEE ; Hee Joon YU ; Joung Soo KIM
Korean Journal of Dermatology 2017;55(5):318-319
No abstract available.
Cyclosporine*
;
Pityriasis Rubra Pilaris*
;
Pityriasis*
3.Recalcitrant Pityriasis Rubra Pilaris Treated with Ustekinumab
Myeong Heon CHAE ; Jee Yon SHIN ; Ji Yeoun LEE ; Tae Young YOON
Korean Journal of Dermatology 2019;57(2):101-102
No abstract available.
Pityriasis Rubra Pilaris
;
Pityriasis
;
Ustekinumab
4.Familial Pityriasis Rubra Pilaris in Siblings
Soo Han WOO ; Sang Woo PARK ; Hyun Bin KWAK ; Su Kyung PARK ; Seok Kweon YUN ; Han Uk KIM ; Jin PARK
Korean Journal of Dermatology 2019;57(2):97-98
No abstract available.
Humans
;
Keratoderma, Palmoplantar
;
Pityriasis Rubra Pilaris
;
Pityriasis
;
Siblings
5.A Case of Acquired Acrodermatitis Enteropathica Mimicking Pityriasis Rubra Pilaris in an Adult with Normal Serum Zinc Levels.
Kihyuk SHIN ; Hyunju JIN ; Hyang Suk YOU ; Jeong Min KIM ; Woo Haing SHIM ; Gun Wook KIM ; Hoon Soo KIM ; Hyun Chang KO ; Moon Bum KIM ; Byung Soo KIM
Korean Journal of Dermatology 2018;56(3):227-229
No abstract available.
Acrodermatitis*
;
Adult*
;
Humans
;
Pityriasis Rubra Pilaris*
;
Pityriasis*
;
Zinc*
6.A Case of Pityriasis Rubra Pilaris Treated with Etretinate.
Bong Goo LEE ; Moo Hyung LEE ; Nack In KIM ; Choong Rim HAW
Korean Journal of Dermatology 1987;25(6):777-781
We report herein a case of pityriasis rubra pilaris in a 39-year-old male, who had erythematous scaly patches on the face, trunk and extremities for one year. The skin lesion showed well defined plaques on the elbow and knee joint areas, and exfoliative hyperkeratotic sheets with fissures on the palms and soles. He had no family and past history of such skin lesion. He was treated with etretinate lmg/kg/day for 1 week initially, and then tapered off 0.5mg/kg/day for 5 weeks with marked improvement. There was no exacerbation and recurrence of the skin lesion for about 1 year.
Acitretin*
;
Adult
;
Elbow
;
Etretinate*
;
Extremities
;
Humans
;
Knee Joint
;
Male
;
Pityriasis Rubra Pilaris*
;
Pityriasis*
;
Recurrence
;
Skin
7.A Case of Pityriasis Rubra Pilaris Associated with Incidental Acantholysis.
Yang Hoon CHO ; Mu Hyoung LEE ; Choong Rim HAW
Annals of Dermatology 1995;7(4):354-357
Pityriasis Rubra Pilaris is a rare, chronic, mildly inflammatory disease characterized by fine acuminate follicular papules with orange-red to salmon-colored scaling of the skin and erythroderma that surround islands of normal, uninvolved skin, particular in the trunk. Most patients also develop palmoplantar hyperkeratosis in the early course of the disease. Focal acantholysis occurring in pityriasis rubra pilaris is an unusual and incidental histologic finding within the spectrum of histologic change of the disease. No case featuring this concomitant histologic finding has been reported in the Korean literatures up to date. We report a case of focal acantholysis occurring in a patient with the clinical features of pityriasis rubra pilaris which may be considered as an incidental finding.
Acantholysis*
;
Dermatitis, Exfoliative
;
Humans
;
Incidental Findings
;
Islands
;
Pityriasis Rubra Pilaris*
;
Pityriasis*
;
Skin
8.A Clinical Study of 30 Cases of Pityriasis Rubra Pilaris.
Kyung Sook KWON ; Kyung Hyung SEO ; Ho Sun JANG ; Tae Ahn CHUNG
Korean Journal of Dermatology 1996;34(6):924-932
BACKGROUND: Pityriasis rubra pilaris (PRP) is a rare disease characterized by widespread follicular acuminate papules. Traditionally, two forms have been described : hereditary (juvenile) and acquired (generally aduIrt). A.substantial contribution, however, suggests that further subdivision is appropriate. OBJECTIVE: The purpose of this study was to investigate clinicopathologic features of PRP and to compare the results of clinical classification with Griffiths' classification. METHODS: The retrospective clinicopathologic study carried out in 30 cases of PRP over the last 30 years. RESULTS: 1. The incidence of type lV was 38.5%. For both type I and III it was 30.8%. The onset ages of the type I, III, and lV were 36.1, 6.0, and 96 years respectively. 2. The most common site of initial involvement was the palms, and the most common involvement site during the diease course was the dorsa of palms and feet. The incidence involved in the whole body was 46.6%. 3. The incidences of insidious and acute onset were 60% and 40% respectively. No case had the family history of PRP. 4. In the histopathologic study, diffuse hyperkeratosis, acanthosis, and mild dermal infiltrations were found in all cases. Follicular pluggings were observed in 93.3% of cases CONCLUSION: We investigated the clinical classifications and clinicopathologic features of PRP. We think that more studies such as prognosis and treatment of PRP should be achieved in the near future.
Classification
;
Foot
;
Humans
;
Incidence
;
Pityriasis Rubra Pilaris*
;
Pityriasis*
;
Prognosis
;
Rare Diseases
;
Retrospective Studies
9.A Case of Acantholytic Dyskeratotic Epidermal Nevus.
Hyun Joong JOO ; Eui Chang CHUNG ; Ai Young LEE
Korean Journal of Dermatology 2002;40(8):997-998
Acantholytic dyskeratosis is seen in Darier's disease, transient acantholytic dermatosis and warty dyskeratoma. It is also occasionally observed incidental histological finding in pityriasis rosea, pityriasis rubra pilaris and is occasionally found in linear epidermal nevus. A 10-month-old boy presented linear hyperkeratotic plaques on the right sole and the left hand along with erythematous scaly papules on the posterior neck, the left axilla and the face. Histological findings showed acantholytic dyskeratosis with common histopathological findings of epidermal nevus. Acantholytic dyskeratosis is an occasional finding in linear epidermal nevus, but has been rarely reported in an infant(5 cases reported in 20 years). We report a case of linear epidermal nevus with acantholytic dyskeratosis in an infant.
Axilla
;
Darier Disease*
;
Hand
;
Humans
;
Infant
;
Male
;
Neck
;
Nevus
;
Pityriasis Rosea
;
Pityriasis Rubra Pilaris
;
Skin Diseases
10.The Effect of Combination Treatment with Oral Etretinate (Ro 10 - 9359) and Vitamin E on Psoriasis Vulgaris.
Sung Nack LEE ; Jung Bock LEE ; Chung Koo CHO ; Hae Eul LEE ; Soo Chan KIM ; Duck Hyun KIM ; Dong Sik BANG ; Seung Hun LEE ; Han Sung PARK ; Hong Il KOOK ; K B MYUNG ; C J KOH ; S I CHUN ; H J KIM ; D H KIM ; J H KIM
Korean Journal of Dermatology 1984;22(2):148-154
Etretinate(Ro 10-9359), an aromatic analogue of vitamin A acid, has been known to be effective in the treatment of psoriasis, Darier's disease, pityriasis rubra pilaris, ichthyosis, and palmoplantar keratoderma when administered orally. In this experiment, we compared the therapeutic and side effects between a group with high dose therapy(initially 75mg of etretinate a day) and an another group with low dose therapy(initially 40mg of etretinate a day). We also observed whether the pretreatment followed by combined treatment with vitamin E could potentiate the therapeutic effect as well as reduce the side effects of oral etretinate. This experiment comprised 102 moderate to severe psoriatic patients. The following results were obtained from this experiment. 1. Fifty-six among 92 patients(61%) who were treated with etretinate for more than 4 weeks showed good to excellent therapeutic effect. 2 The high dose therapy was more effective, but showed more side effects than low dose therapy. 3 Vitamin E did not potentiate the effect of etretinate. In low dose therapy, the pretreatment followed by combined treatment with vitamin E showed a tendency to reduce the side effects of etretinate.
Acitretin*
;
Darier Disease
;
Etretinate*
;
Humans
;
Ichthyosis
;
Keratoderma, Palmoplantar
;
Pityriasis Rubra Pilaris
;
Psoriasis*
;
Tretinoin
;
Vitamin E*
;
Vitamins*